NO133892B - - Google Patents

Download PDF

Info

Publication number
NO133892B
NO133892B NO2578/72A NO257872A NO133892B NO 133892 B NO133892 B NO 133892B NO 2578/72 A NO2578/72 A NO 2578/72A NO 257872 A NO257872 A NO 257872A NO 133892 B NO133892 B NO 133892B
Authority
NO
Norway
Prior art keywords
chloro
sulfamoyl
furfuryl
anthranilic acid
melting point
Prior art date
Application number
NO2578/72A
Other languages
English (en)
Norwegian (no)
Other versions
NO133892C (nl
Inventor
S Schoenberg
H Yellin
Original Assignee
Teva Middle East Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL37345A external-priority patent/IL37345A/xx
Priority claimed from IL38812A external-priority patent/IL38812A/xx
Application filed by Teva Middle East Pharm filed Critical Teva Middle East Pharm
Publication of NO133892B publication Critical patent/NO133892B/no
Publication of NO133892C publication Critical patent/NO133892C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO2578/72A 1971-07-20 1972-07-19 NO133892C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL37345A IL37345A (en) 1971-07-20 1971-07-20 Derivatives of 4-chloro-5-sulfamoyl-anthranilic acid,their preparation and pharmaceutical compositions comprising them
IL38812A IL38812A (en) 1972-02-22 1972-02-22 Derivatives of n-furfuryl-4-chloro-5-sulfamoylanthranilic acid,their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
NO133892B true NO133892B (nl) 1976-04-05
NO133892C NO133892C (nl) 1976-07-14

Family

ID=26320464

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2578/72A NO133892C (nl) 1971-07-20 1972-07-19

Country Status (23)

Country Link
US (1) US3860582A (nl)
JP (1) JPS516660B1 (nl)
AR (1) AR212746A1 (nl)
AT (1) AT315827B (nl)
AU (1) AU446727B2 (nl)
BE (1) BE786432A (nl)
CA (1) CA1024988A (nl)
CH (1) CH566972A5 (nl)
CS (1) CS183664B2 (nl)
DD (1) DD99572A1 (nl)
DK (1) DK133503B (nl)
ES (1) ES404965A1 (nl)
FR (1) FR2146249B1 (nl)
GB (1) GB1364366A (nl)
HU (1) HU164158B (nl)
IE (1) IE36684B1 (nl)
NL (1) NL151705B (nl)
NO (1) NO133892C (nl)
OA (1) OA04139A (nl)
PH (1) PH10267A (nl)
RO (1) RO60274A (nl)
SE (1) SE384675B (nl)
SU (1) SU455533A3 (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2334973A1 (de) * 1973-07-10 1975-01-23 Boehringer Mannheim Gmbh Neue biphenyl-derivate
FR2302101A1 (fr) * 1975-02-27 1976-09-24 Joullie International Sa Nouveaux derives de l'acide chloro-4
DE3006686A1 (de) * 1980-02-22 1981-08-27 Hoechst Ag, 6000 Frankfurt 5-sulfamoyl-orthanilsaeuren, verfahren zu ihrer herstellung und ihre verwendung als heilmittel
CA2695613A1 (en) * 2006-12-19 2008-06-26 Pharmos Corporation Sulfonamide derivatives with therapeutic indications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2908716A (en) * 1957-04-08 1959-10-13 Crown Zellerbach Corp Preparing organic sulfides
US3567714A (en) * 1965-09-03 1971-03-02 Smith Kline French Lab N - (oxa- or thiacycloalkyl)methyl-5-sulfamoylanthranilic acid derivatives
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
US3678039A (en) * 1967-04-27 1972-07-18 Lincoln Harvey Werner 4-trifluoromethyl-anthranilic acids

Also Published As

Publication number Publication date
IE36684L (en) 1973-01-20
AT315827B (de) 1974-06-10
GB1364366A (en) 1974-08-21
PH10267A (en) 1976-10-20
CS183664B2 (en) 1978-07-31
SE384675B (sv) 1976-05-17
ES404965A1 (es) 1976-04-01
FR2146249A1 (nl) 1973-03-02
OA04139A (fr) 1979-11-30
DD99572A1 (nl) 1973-08-20
DE2235400B2 (de) 1977-06-30
NL151705B (nl) 1976-12-15
CH566972A5 (nl) 1975-09-30
US3860582A (en) 1975-01-14
AU446727B2 (en) 1974-03-28
CA1024988A (en) 1978-01-24
BE786432A (fr) 1972-11-16
AU4430872A (en) 1974-02-21
IE36684B1 (en) 1977-02-02
SU455533A3 (ru) 1974-12-30
DK133503B (da) 1976-05-31
RO60274A (nl) 1976-09-15
DK133503C (nl) 1976-10-18
NL7210054A (nl) 1973-01-23
HU164158B (nl) 1973-12-28
FR2146249B1 (nl) 1975-10-17
AR212746A1 (es) 1978-09-29
DE2235400A1 (de) 1973-02-01
NO133892C (nl) 1976-07-14
JPS516660B1 (nl) 1976-03-01

Similar Documents

Publication Publication Date Title
US2554816A (en) Heterocyclic sulfonamides and methods of preparation thereof
JPS5922697B2 (ja) ビス−(メタ−アミジノフエノキシ)−化合物
JPS6039678B2 (ja) 新規インド−ル誘導体の製法
NO764039L (nl)
NO133892B (nl)
US2935514A (en) Benzimidazoles
Birtwell 356. 2-Cyanoamino-4: 6-dimethylpyrimidine and complexes formed by pyrimidines with urea and related compounds
Bailey et al. The Mannich Reaction with 1, 2-Dibenzoylethane1, 2
KR880002706B1 (ko) 설포닐 우레아의 제조방법
Heymann et al. Derivatives of p, p'-Diaminodiphenyl Sulfone1a
Bosin et al. Routes of functionalized guanidines. Synthesis of guanidino diesters
EP0021229B1 (en) Arylazo compounds, their preparation and their use
US3350407A (en) Sulfur containing pyrazole derivatives
DE2129236A1 (de) Neue Sulfonylsemicarbazide und Verfah ren zu deren Herstellung sowie ihre Ver Wendung als Arzneimittel
US2748121A (en) 6-nitroaryl derivatives of 2-amino-4-pyrimidols
US2456051A (en) N'-dodecanoylsulfanilamides
US3360516A (en) N-[4-(2, 6-dimethylpyrimidyl)]3, 5-dinitrobenzamide
Sato et al. Studies on Organic Sulfur Comqounds. I. Thioformyl Phenylhydrazine
US3459742A (en) Sulfanilamide derivatives and processes
Dodson et al. The Reaction of Ethyl α-and γ-Bromoacetoacetates with S-Alkylisothioureas
SU598560A3 (ru) Способ получени замещенных 2-хлор-4-алкиламино-6цианоалкиламино-1,3,5триазинов
DE2558150A1 (de) Neue benzylpyrimidine
US2697095A (en) Penicillin salts of glycine-diphenylamides
Clarke et al. BENZENESULFONYLGUANIDINES1
US3991188A (en) 3-Alkyl-4-sulfamoyl-aniline therapeutic compositions